These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Synthesis of isoquinolines and heterocycle-fused pyridines via three-component cascade reaction of aryl ketones, hydroxylamine, and alkynes. Zheng L; Ju J; Bin Y; Hua R J Org Chem; 2012 Jul; 77(13):5794-800. PubMed ID: 22702218 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of novel nonpeptide angiotensin II receptor antagonists: imidazo[4,5-c]pyridine derivatives with an aromatic substituent. Kiyama R; Fuji M; Hara M; Fujimoto M; Kawabata T; Nakamura M; Fujishita T Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):450-60. PubMed ID: 7774028 [TBL] [Abstract][Full Text] [Related]
28. Optimization of the 4-aryl group of 4-aryl-pyridine glucagon antagonists: development of an efficient, alternative synthesis. Smith RA; Hertzog DL; Osterhout MH; Ladouceur GH; Korpusik M; Bobko MA; Jones JH; Phelan K; Romero RH; Hundertmark T; MacDougall ML; Livingston JN; Schoen WR Bioorg Med Chem Lett; 2002 May; 12(9):1303-6. PubMed ID: 11965376 [TBL] [Abstract][Full Text] [Related]
29. Nonpeptidic inhibitors of human neutrophil elastase. 7. Design, synthesis, and in vitro activity of a series of pyridopyrimidine trifluoromethyl ketones. Edwards PD; Andisik DW; Strimpler AM; Gomes B; Tuthill PA J Med Chem; 1996 Mar; 39(5):1112-24. PubMed ID: 8676347 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of 2-phenol-4-chlorophenyl-6-aryl pyridines as topoisomerase II inhibitors and cytotoxic agents. Thapa P; Kadayat TM; Park S; Shin S; Thapa Magar TB; Bist G; Shrestha A; Na Y; Kwon Y; Lee ES Bioorg Chem; 2016 Jun; 66():145-59. PubMed ID: 27174797 [TBL] [Abstract][Full Text] [Related]
31. A general [3 + 2 + 1] annulation strategy for the preparation of pyridine N-oxides. Davies IW; Marcoux JF; Reider PJ Org Lett; 2001 Jan; 3(2):209-11. PubMed ID: 11430036 [TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens. Heiman DF; Senderoff SG; Katzenellenbogen JA; Neeley RJ J Med Chem; 1980 Sep; 23(9):994-1002. PubMed ID: 7411555 [TBL] [Abstract][Full Text] [Related]
35. Novel acyl-CoA:cholesterol acyltransferase inhibitors. Synthesis and biological activity of 3-quinolylurea derivatives. Tawada H; Harcourt M; Kawamura N; Kajino M; Ishikawa E; Sugiyama Y; Ikeda H; Meguro K J Med Chem; 1994 Jun; 37(13):2079-84. PubMed ID: 8027989 [TBL] [Abstract][Full Text] [Related]
36. [Hypocholesteremic and hypolipemic effects of p-chlorophenoxy-alpha-isobutyrate of 3-hydroxymethylpyridine hydrochloride]. Marmo E; Imperatore AM; Caputi A; Cataldi S Farmaco Prat; 1971 Oct; 26(10):557-84. PubMed ID: 5157541 [No Abstract] [Full Text] [Related]
37. Hypocholesteremic agents. 2. Cyclohexane and indan derivatives. Villani FJ; Ellis CA J Med Chem; 1970 Nov; 13(6):1245-6. PubMed ID: 5479882 [No Abstract] [Full Text] [Related]
38. [Studies on hypolipidemic agents. III. Syntheses and hypocholesteremic activities of morpholino and trifluoromethyl derivatives (author's transl)]. Miyoshi F; Nagao K Yakugaku Zasshi; 1974 Aug; 94(8):1028-32. PubMed ID: 4472623 [No Abstract] [Full Text] [Related]
39. Synthesis and biological activity of 2,4-di-p-phenolyl-6-2-furanyl-pyridine as a potent topoisomerase II poison. Karki R; Park C; Jun KY; Kadayat TM; Lee ES; Kwon Y Eur J Med Chem; 2015 Jan; 90():360-78. PubMed ID: 25437622 [TBL] [Abstract][Full Text] [Related]
40. Novel synthesis of [1]-benzothiepino[5,4-b]pyridine-3-carbonitriles and their anti-inflammatory properties. Girgis AS; Mishriky N; Ellithey M; Hosni HM; Farag H Bioorg Med Chem; 2007 Mar; 15(6):2403-13. PubMed ID: 17267228 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]